Related Experiment Videos
[Some problems of the therapy of chronic glomerulonephritis]
Insights
Therapy effectiveness for chronic glomerulonephritis depends on clinical and morphological factors. Glucocorticoids and cytostatics are less effective with nephrotic syndrome or recurrent disease.
Area of Science:
- Nephrology
- Internal Medicine
Context:
- Chronic glomerulonephritis exacerbations in 416 patients were studied.
- Therapeutic outcomes were analyzed throughout the disease course.
Purpose:
- To determine the influence of clinical and morphological factors on therapy outcomes in chronic glomerulonephritis.
- To compare the efficacy of different treatment strategies based on disease characteristics.
Summary:
- Therapy efficacy, including glucocorticoids, cytostatics, anticoagulants, and antiaggregants, was reduced by nephrotic syndrome and continuous recurrence.
- Membranous glomerulonephritis showed poorer treatment results compared to mesangioproliferative and membranoproliferative glomerulonephritis.
- Mesangioproliferative glomerulonephritis treatment was more effective than membranoproliferative, due to less frequent active disease and nephrotic syndrome.
Impact:
- Findings highlight the importance of considering specific clinical and morphological features for optimizing glomerulonephritis treatment.
- Identifies patient subgroups that may benefit from tailored therapeutic approaches for better outcomes.
Abstract:
A study of the results of therapy of exacerbations of chronic glomerulonephritides in 416 patients during the entire course of the disease has shown their dependence on the clinical and, to a lesser degree, on morphological peculiarities of disease. With the same anatomy of the process, the efficacy of glucocorticoids, cytostatics and their combinations with anticoagulants and antiaggregants was less in the presence of the nephrotic syndrome and got lower twice or thrice in patients with a tendency to continuous recurrence. The results of the use of all types of therapy in groups of patients identical by their clinical characteristics were worse in membranous glomerulonephritis and did not differ significantly in mesangioproliferative and membranoproliferative glomerulonephritides. The treatment of the latter was less effective than that of mesangioproliferative glomerulonephritis because of higher frequency of an active course and development of the nephrotic syndrome.